Merck
MRK
#43
Rank
C$501.91 B
Marketcap
C$203.44
Share price
0.52%
Change (1 day)
64.19%
Change (1 year)

Merck (MRK) - Cash on Hand

Cash on Hand as of June 2026 : C$10.18 Billion

According to Merck's latest financial reports the company has C$10.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Merck - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31C$19.94 B1.54%
2024-12-31C$19.64 B108.8%
2023-12-31C$9.40 B-47.45%
2022-12-31C$17.90 B73.49%
2021-12-31C$10.31 B0.52%
2020-12-31C$10.26 B-24.79%
2019-12-31C$13.64 B13.03%
2018-12-31C$12.07 B13.01%
2017-12-31C$10.68 B-44.56%
2016-12-31C$19.27 B3.47%
2015-12-31C$18.62 B2.11%
2014-12-31C$18.24 B-2%
2013-12-31C$18.61 B15.97%
2012-12-31C$16.05 B5.39%
2011-12-31C$15.22 B24.87%
2010-12-31C$12.19 B20.69%
2009-12-31C$10.10 B51.48%
2008-12-31C$6.67 B-18.76%
2007-12-31C$8.21 B-19.06%
2006-12-31C$10.14 B-44.28%
2005-12-31C$18.20 B113.79%
2004-12-31C$8.51 B57.31%
2003-12-31C$5.41 B-31.06%
2002-12-31C$7.85 B49.96%
2001-12-31C$5.23 B-17.86%
2000-12-31C$6.37 B38.01%
1999-12-31C$4.61 B15.27%
1998-12-31C$4.00 B149.26%
1997-12-31C$1.60 B-13.22%
1996-12-31C$1.85 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
C$29.59 B 190.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.96 B 7.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$16.67 B 63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.40 B 2.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$12.76 B 25.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.94 B 95.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.33 B 1.49%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$15.77 B 54.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.86 B-42.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$5.21 B-48.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel